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Summary: Glomerular basement membranes were isolated from kidneys of human diabetics and non-
diabetics. Albumin and immunoglobulin G content of glomerular basement membranes äs determined after
protease digest was higher in the diabetic group while lower values were obtained for heparan sulphate.
Nonenzymatic glucosylation of whole glomerular basement membranes and tendon tissue was significantly
elevated in diabetic subjects. Correlation of the determined parameters suggest that Charge and size selective
properties are altered in diabetic glomeruli. Serum albumin and albumin deposited in glomerular basement
membranes showed the same content of nonenzymatically bound glucose in a normal and in a diabetic subject,
respectively. Thus it would appear that in human diabetes the glucosylated albumin does not underly in-
creased transcapillary transport äs was reported in vitro.
Änderungen der menschlichen glomerulären Basalmembran bei Diabetes mellitus
Zusammenfassung: Glomeruläre Basalmembranen wurden aus Nieren von Diabetikern und Nichtdiabetikern
isoliert. Der nach Pronaseverdauung bestimmte Albumin- und Immunglobulingehalt der glomerulären Basal-
membranen war beim diabetischen Kollektiv höher als beim Vergleichskollektiv, während der Heparansulfat-
gehalt des diabetischen Kollektivs niedriger war als im Vergleichskollektiv. Sowohl glomeruläre Basalmem-
branen als auch Sehnengewebe waren bei Diabetikern signifikant höher nicht-enzymatisch glucosyliert. Die
Korrelationen der gemessenen Kenngrößen legen die Vermutung nahe, daß bei diabetischen Glomeruli so-
wohl die Ladungs- als auch die Poreneigenschaften verändert sind. Sowohl bei Diabetikern wie Nicht-
diabetikern war das Serümalbümin und das aus glomerulären Basalmembranen isolierte Albumin gleich hoch
glucosyliert. Dieses Ergebnis zeigt, anders als in vitro Studien, daß glucosyliertes Albumin von Diabetikern
nicht schneller transkapillar transportiert wird als das der Kontrollgruppe.
Introduction
Microvascular lesions constitute a cardinal feature of
diabetic late complications. Althöugh it has been
recognized for some time that ulträstructural and
biochemical alterations of the renal glomerular base-
ment membrane coincide with diabetic nephropathy,
this relationship is not fully understood. Biochemical
analysis of glomerular basement membrane from
normal and diabetic subjects revealed alterations in
neutral sugar (!) and heparan sulphate content (2).
Further, immunofluorescence studies of diabetic
kidneys have demonstrated intense linear staining
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for human albumin and immunoglobulin G in glo-
merular basement membrane and Bowman's capsule
(3, 4) consistent with clinical findings of an acceler-
ated transcapillary escape of serum proteins in dia-
betes (5). Changes in the composition of basement
membranes are likely to be responsible for function-
al disturbances and hence for the development of ca-
pillary disease. We have therefore quantified the
amount of nonenzymatically bound glucose, of hepa-
ran sulphate, and of albumin and immunoglobulin G
of glomerular basement membrane prepared from
kidney obtained at autopsy from normal and diabetic
humans.
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Materials and Methods
Kidneys from six subjects with longstanding (6-20 years, mean
13.2) maturity-onset diabetes and from ten normal subjects were
obtained at autopsy. The mean age (ränge) for diabetics and non-
diabctics was 63.8 (46-83) years and 66.2 (40-86) years, re-
spectively. Data on diagnosis, onset, duration, therapy and on dia-
betic late complications were taken from the case histories. Neph-
ropathy was diagnosed at autopsy by macroscopic and microscop-
ic examination. The kidneys were maintained at -20 °C until
thavved for Isolation and preparation of glomerular basement
membrane.
Glomeruli were isolated from the cortical portion of kidneys by
the sieving procedure through stainless-steel screens according to
Krakower et al. (6). Isolation of glomeruli and of glomerular base-
ment membrane was monitored by phase-contrast microscopy.
Glomerular basement membranes were obtained by sonification
and detergent treatment äs described by Meezan et al. (7).
Precisely weighted portions of pure glomerular basement mem-
brane (10-30 mg) were treated with highly purified collagenase
(Sigma St. Louis Mo. USA) äs described by Parthasarathy et al.
(S). After three days the samples were centrifuged and the super-
natants removed for determination of albumin and immunoglo-
bulin G. The residue was resuspended in 0.1 mol/1 Tris-acetate
pH = 8.0 and further digested with pronase äs described in I.e.
(8). After three days traces of insoluble material were removed by
centrifugation and the heparan sulphate-containing supernatant
was chromatographed on DEAE-cellulose (8). Heparan sulphate-
containing fractions eluted with 3 mol/1 pyridine formale were
lyophilised. The uronic acid content was determined by a micro-
modification of the method of Blumenkrantz et al. (9) using glucu-
ronic acid äs Standard. Purity and chemical nature of glycosamino-
glycan was assessed by electrophoresis and nitric acid treatment
according to I.e. (8).
Albumin and immunoglobulin G were determined immunologi-
cally with the Immunochemistry Analyzer (Beckman Inc. Brea
USA). 5, 10 or 20 mg/1 albumin or immunoglobulin G were dis-
solved in the collagenase digestion buffer äs Standards. The assay
was linear from 5-50 mg/1 and duplicates did not differ by more
than 15%. For purification of albumin trapped in the glomerular
basement membrane, collagenase digest supernatants from nor-
mal and diabetic basement membranes were pooled, dialysed
against water and lyophilised. The residue was dissolved in 600
HaO and purified by gel filtration. The high performance liquid
Chromatograph consisted of a solvent delivery System Model 6000
A, an automatic injector, Model WISP 71ÖfA and an UV-absor-
bance detector, Model 440 (all from Waters Ass. Milford MA
01757). The column G 4000 SW (60 cm x 0.75 cm) was obtained
from LKB (Munich, GFR). Phosphate buffered saline was used äs
eluent and the fractions were monitored at 280 and 254 nm with
absorbance unit füll scale = 0.05. The column was calibrated with
human serum albumin (Behring, Marburg, GFR). Fractions
(1.5ml) were collected and tested for albumin content äs de-
scribed above. Albumin eluted äs a single peäk well separated
from other proteins. The purity of the albumin fractions was as-
sessed by immunoassay/A280 nm ratios. The fraction with high al-
bumin content (at least 85% pure) was lyophilised, hydrolysed,
and analysed for nonenzymatically bound glucose äs described
previously (10). Nonenzymaticaily bound glucose of glomerular
basement membrane or tendon tissue was determined according
to I.e. (11).
Results
The amount of nonenzymatically bound glucose of
tendon and glomerular basement membrane from
diabetic and nondiabetic individuals is presented in
figure 1. On the average, the levels in diabetics are at
least two times higher than in non^-diabetics, the dif-
ference being significant at P < 0.005 for tendon and
glomerular basement membrane. None of the vahies
of the diabetic group lies within the normal ränge.
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Fig. 1. Albumin, immunoglobulin G and uronic acid content of human glomerular basement membrane from kidney of normal (O) and
diabetic (O) subjects.
Nonenzymatic glucosylätion of tendon and glomerular basement membrane of the same subjects was also determined and related
to phenylalamine content. v ;
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These results are in agreement with previous obser-
vations (11). Figure l further illustrates that glomer-
ular basement membrane of diabetic kidneys also
contained higher amounts of albumin and immuno-
globulin G äs compared to non-diabetics. The differ-
ences were significant at a level of P < 0.05. Michael
and Brown (12) using a different method found a
mean albumin content of 1.31 and 2.25 g/mg glo-
merular basement membrane for normal and diabet-
ic glomerular basement membrane, respectively, in
good agreement with our results (1.55 and 2.05).
That our values for diabetic glomerular basement
membrane are somewhat lower is probably due to
the fact that we studied an unselected diabetic group
whereas Michael and Brown (12) were dealing with
surgically removed kidneys from diabetic patients
suffering from terminal nephropathy and destined
for renal transplantation.
That albumin was not merely adsorbed to glomeru-
lar basement membrane during preparation but
firmly bound (probably trapped in the glomerular
basement membrane lattice) was indicated from the
time course of its release during collagenase incuba-
tion. After one hour no albumin could be detected.
After one day 40—60% of the albumin was liberat-
ed, and after two days 80—100% was present in the
supernatant with little or no change after three days
of incubation.
From our data in figure l it appears that there is also
more immunoglobulin G present in glomerular base-
ment membrane of diabetic subjects (mean 2.03 g/
mg) than in glomerular basement membrane of nor-
mal individuals (mean 1.40 g/mg) although the dif-
ference is significant only at P < 0.05. To our knowl-
edge no quantitative data on the immunoglobulin G
content of human glomerular basement membrane
exist so far in the literature. From immunofluores-
cence studies there is however evidence that in dia-
betic patients immunglobulin G passes the capillary
easier than in normale (5).
Confirming recent findings by I.e. (2) figure l fur-
ther indicates that glomerular bäsement membrane
from diabetic subjects contains less heparan sulfate
(determined äs hexuronic acid) äs compared to glo-
merular basement membrane obtained from normal
individuals.
Although the uronic acid content covers a large
ränge the difference is significant at the P < 0.01
level. Pertaining to the development of diabetic mi-
croangiopathy it has been reported that albumin
with a higher ("diabetic") level of nonenzymatically
bound glucose can pass the capillary membranes
much faster than normal albumin, in vitro (13). Ac-
cordingly one should expect an enrichment of the
higher glucosylated albumin species in extracellular
deposits. Using a sensitive and specific method (10)
we were able to quantify nonenzymatically bound
glucose in 30-50 g of albumin isolated from glo-
merular basement membranes. The content of ly-
sine-bound glucose of the albumin from glomerular
basement membrane of normals and diabetics was
3.8 and 10.4 nmol/mg protein respectively; these
values compare well with the levels of glycosylated
albumin isolated from the serum of normals (mean
3.6 ± 0.3, n ± 52) and diabetics (mean 10.8 ± 3.3, n
= 52). These results are not consistent with a prefer-
ential extravasation and deposition of (higher) gluc-
osylated albumin, at least in the case of glomerular
basement membranes.
Discussion %
The present study confirms previous results that hu-
man renal diabetic basement membranes contain a
higher amount of albumin (5) and a lower amount of
heparan sulphate (2) than do membranes derived
from normal kidney. Furthermore we detected
higher amounts of immunoglobulin G in glomerular
basement membrane of diabetics äs compared to
normals. When immunoglobulin G and albumin con-
tents of glomerular basement membrane were corre-
lated (fig. 2) a reasonable, positive correlation was
obtained. If, äs currently believed (14—16), the per-
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Fig. 2. Comparison of albumin and immunoglobulin G content in
glomerular basement membrane from kidney of normal
(O) and diabetic (·) subjects. y = 0.83x -l- 0.20; r =
0.619.
The serum proteins were released from glomerular base-
ment membrane after digestion with collagenase äs de-
scribed under methods.
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meability of glomerular basement membrane is de-
fined by pore size and anionic sites, a knowledge of
the number of ihcluded proteins and their Charge
and size differences should permit predictions äs to
the possible changes in filtration properties. Deple-
tion of negative Charge of the bas^l membrane is
likely to enhance transglomerular passage of circu-
lating negatively charged proteins like albumin
(isoelectric point 4.7), whereas this is not expected
to apply for immunoglobulins G which are essential-
ly neutral in plasma (isoelectric point 6.6—8.0). In
agreement with this view is the observation that pro-
teinuria of diabetics is of high selectivity (17, 18).
Our results on the composition of glomerular base-
ment membrane may be interpreted äs a combina-
tion of defects in the diabetic state — i.e. a decrease
in negative Charge and an increase in pore size. Sig-
nificantly decreased heparan sulphate per amino
acid content (8) or per mg glomerular basement
membrane (this study) was shown for the diabetic
kidney. However, äs the negative Charge is localised
at the laminae rarae externa and interna (19) it is
possible that the reduction in heparan sulphate in di-
abetes is simply a matter of calculation relative to a
greater mass of Collagen (basement membrane-
thickening). On the other hand, reduced 35SOi~ in-
corporation in glomerular basement membrane, in-
dicating reduced heparan sulphate synthesis, has
been observed in diabetic rats (20, 21). When albu-
min or immunoglobin G content and uronic acid
content of glomerular basement membrane were
compared (tab. 1) a weak negative correlation was
Tab. 1. Linear correlation of albumin, immunoglobulin G and
uronic acid content of glomerular basement membrane
from nondiabetic and diabetic individuals with nonenzy-
matic glucosylation of tendon and glomerular basement
membrane and the albumin, immunoglobulin G and uron-
ic acid content of glomerular basement membrane, re-
spectively.
Albumin Uronic acid Nonenzymatic
glucosylation of
glomerular tendon
basement
membrane
Albumin —
Immuno-
globulin G 0.62
Uronic acid —
-0.40
-0.63
-
0.50
0.37
-0.52
0.65
0.41
-0.19
found (-0.40 and -0.63). Thus defective sieving
with respect to molecular size is likely to occur in
diabetic glomeruli, and a reduced negative Charge
may also influence the permeability properties. My-
ers et al. (22), stüdying extensively the glomerular
barrier function in normal and diabetic subjects,
found increased urinary immunoglobulin G excre-
tion when urinary albumin concentration was in-
creased. They concluded that the development of
large pores within the glomerular membrane in ad-
vanced diabetic nephropathy permits passage of
large plasma proteins into the urine.
Cohen et al. (23) suggested that nonenzymatic gluc-
osylation of lysine -amino^groups of glomerular
basement membrane interferes with crosslinking in
the Collagen framework thus leading to the develop-
ment of larger pores. As indicated in table l we have
found only very weak correlation between nonenzy-
matic glucosylation of glomerular basement mem-
brane and albumin or immunoglobulin G. Glomeru-
lar basement membrane from diabetic kidneys with
the highest immunoglobulin G content showed the
lowest nonenzymatic glucosylation, which may be
(xplained by a shorter half life of glomerular base-
uent membrane collagen (repair mechanism). Tak-
en together, our results do not Support the view that
nonenzymatic glucosylation of glomerular basement
membrane per se changes filtration properties.
As nonenzymatic glucosylation of tendon tissue re-
flects probably the achievement of metabolic control
in diabetics over a long period of time (11), these
values were also correlated with^the albumin and im^·
munoglobulin G Contents of glomerular basement
membrane. A rather good positive correlation was
found (tab. 1) confirming former results that lorig
term bad metabolic control of diabetic patients leads
to proteinuria, especially albuminuria. Our findings
suggest that we are not dealing with enhanced non-
enzymatic glucosylation of glomerular basement
membrane leading to diabetic proteinuria, but rather
with "dysregulation" leading to synthesis of defec-
tive basement membrane.
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